Seth Meyers reminds Republicans they’re caught with Trump and completely screwed

Seth Meyers reminded Republicans that Donald Trump will never change and will never drop out of the presidential race, so the GOP is fucked.

Video:

Meyers said: “Who are these people still clinging to the fantasy that Trump is going to have a merciful goodbye? He can’t even bow normally. bow graciously? When he lost in 2020, he sent an army of Oath Keepers and werewolves to kill his own vice president… Seriously, if you think Donald Trump is about to change his personality now at the age of 76 after eight years in politics and an attempted coup Stay in power, you’re crazier than those Qanon people who believe JFK Jr. will rise from the dead. If your personality changes at 76, you won’t get recognition. You will be put in a home.”
Subscribe to our newsletter:

The Republican Party wants to get rid of Trump just like they wanted to get rid of Trump in 2016, and they wanted him to stay out of the 2018 and 2022 elections. The problem is that the party lacks a plan to stop Trump and the US without the courage to stand up to the failed ex-president.

Trump will never change, and why should he? There are currently no consequences for him from the Republican Party.
Republicans have figured out Trump is a loser, but they’re too scared to get rid of him, suggesting history will repeat itself in 2024.

Jason is the managing editor. He is also a White House press pool and congressional correspondent for PoliticusUSA. Jason has a bachelor’s degree in political science. His thesis focused on public policy with a specialization in social reform movements.

Awards and professional memberships

Member of the Society of Professional Journalists and the American Political Science Association

FDA approval of Covid photographs and coverings won’t decelerate with the top of the general public well being emergency

Vials and a medical syringe in front of the United States Food and Drug Administration (FDA) logo. The FDA finds the COVID-19 vaccine.

Pavlo Gonchar | flare | Getty Images

The Food and Drug Administration said Tuesday its emergency use approvals for Covid vaccines, tests and treatments will not be affected by the end of the public health emergency this spring.

President Joe Biden plans to end the public health and national emergencies declared three years ago in response to the Covid pandemic in May, the White House said Monday. The public health emergency gave US health officials increased powers to respond more quickly to the pandemic.

However, the FDA’s emergency powers are not directly tied to the public health statement, according to the agency.

Former Health Secretary Alex Azar made separate determinations under the Food, Drugs and Cosmetics Act in February and March 2020 that the circumstances of the pandemic warranted the approval of emergency vaccines, treatments and tests.

The FDA used its emergency powers to authorize it Pfizer, Modern, Johnson&Johnson And Novavax vaccinations. The agency also approved oral antivirals Paxlovid and molnupiravir, several antibody treatments, and numerous tests and other medical devices on an emergency basis.

“Existing Emergency Use Authorizations (EUAs) for devices remain in effect, and the agency may continue to issue new EUAs in the future if the criteria for issuance are met,” the FDA wrote in a post on Twitter Monday.

Emergency approvals allow the FDA to bring medical products to market before they receive full agency approval. This allows the agency to respond more quickly to public health crises.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Eagles participant Josh Sills accused of rape earlier than Tremendous Bowl

Josh Sillsa backup offensive lineman for the Philadelphia Eagles, was charged with alleged rape and kidnapping less than two weeks before his team will compete in the 2023 Super Bowl.

Sills, 25, is accused of sexually assaulting and holding a woman against her will in Ohio in December 2019, Ohio prosecutors said in a statement, adding that the crime was immediately reported and police were investigating have. On January 31, the Guernsey County Common Pleas Court charged the athlete with one count of rape and one kidnapping, both first-degree crimes.

According to a police report obtained by ESPN, an officer was dispatched to an emergency room at a Cambridge, Ohio, hospital on Dec. 5, 2019, to receive a report of a sexual assault.

The alleged victim, a woman, told police that Sills, a friend from high school, dropped her and her cousin off at her cousin’s place of residence and that the NFL player allegedly moved after her cousin left the She climbed back into the truck and later sexually assaulted her in the vehicle. A nurse informed the dispatched officer that the victim had bruises on his mouth.

I need to personal Sherwin-Williams

Sherwin Williams Co: “I want to own it. I’ll tell you why. Everything that could be said negatively about it is out there. I want to come out with a more positive thesis.”

XPO Inc: “Let’s wait for it to come down a little.”

Upstart Holdings Inc: “At the moment it’s a spiral spring, even if it’s not going well. … That’s not my style.”

SoFi Technologies Inc: “It was a good quarter and things are looking up.”

Disclaimer: Cramer’s Charitable Trust owns shares of Wells Fargo.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing free to help you build long-term wealth and invest smarter.

Client Monetary Safety Bureau proposes bank card price regulation

Signage at the Consumer Financial Protection Bureau (CFPB) headquarters in Washington, DC

Andrew Kelly | Reuters

WASHINGTON — The federal government’s Consumer Protection Agency on Wednesday proposed a new rule to ban excessive credit card late fees, potentially reducing them by as much as $9 billion a year.

Congress banned exorbitant credit card fees under the Credit CARD Act in 2009, but an immunity provision introduced by the Federal Reserve Board of Governors allowed card companies to circumvent enforcement standards, said Rohit Chopra, director of the Consumer Financial Protection Bureau.

“More than a decade ago, Congress banned excessive fees for late credit card payments, but companies have exploited a regulatory loophole that has allowed them to avoid scrutiny for charging an otherwise illegal junk fee,” Chopra said. “Today’s proposed rule is designed to save families billions of dollars and ensure the credit card market is fair and competitive.”

The proposal follows a March 2022 report showing that credit card issuers billed consumers $12 billion in late fees in 2020. Many issuers charge the maximum late fee set by the Fed Board in 2010: $30 for the first late payment and $41 for subsequent late payments within six billing cycles. Card issuers that increase fees with inflation are also protected by immunity clauses, according to Chopra.

The CFPB rule proposed on Wednesday would reduce the amount consumers may owe for late payments from as much as $41 to $8, end automatic annual inflation adjustment for provision, and late fees to 25% of cardholder’s limit the minimum payment owed.

Chopra said credit card issuers have made late penalty fees a “core part of their profit model” and that the protections afforded by the credit card law have effectively reduced the overall cost of credit for consumers. The fees disproportionately affect households living paycheck to paycheck, borrowers living in America’s poorest areas, areas where the population is mostly black, and subprime and private label cardholders.

“Markets work best when companies compete on price and services, rather than relying on back-end fees that mask true costs,” Chopra said. “Given their current practices, we expect credit card issuers to increase fees based on inflation as limits continue to rise.”

The CFPB will seek public comments on other possible changes, including whether the proposed rule should apply to all credit card penalties, eliminating the immunity provision altogether, introducing a 15-day courtesy period for credit card holders before assessing late fees, and requiring credit card companies to autopay services as a condition for immunity determinations.

The rule change also follows a request for comment on the Biden administration’s initiative to reduce certain “garbage fees” weighing on American consumers.

Late fees cost American families about $12 billion a year in addition to billions in interest, the CFPB said.

The Fed Board did not immediately respond to a request for comment from CNBC.

The Covid pandemic will push Pfizer’s gross sales to a file $100 billion in 2022

Empty vials of Pfizer-BioNTech vaccines for children against the coronavirus disease (COVID-19) are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, the United States, May 19, 2022.

Hannah Beier Reuters

The ongoing Covid-19 pandemic pushed pharmaceutical company Pfizer’s revenue to a record $100 billion last year, of which nearly $57 billion came from its vaccine and antiviral pill Paxlovid, the company reported on Tuesday.

The vaccine accounted for $37.8 billion, up just 3% from 2021 of Pfizer’s total sales, as demand for the syringes slowed. But sales of its blockbuster antiviral treatment recouped that decline, climbing to $18.9 billion in 2022, Paxlovid’s first full year on the market.

related investment news

CNBC Pro

Pfizer’s combined sales of its Covid vaccine and antiviral treatment generated more sales last year than total sales in 2019, before the pandemic escalated into a global crisis that killed more than 6.8 million and shaken world markets head turned. These results will not be repeated this year.

Pfizer Beats EPS Estimates;  Stock falls to lower full-year forecast

Pfizer told investors it expects revenue to fall by as much as 33% to $67 billion to $71 billion in 2023 as the world emerges from the pandemic and demand for its blockbuster Covid drugs eases.

Sales of Covid vaccines are expected to fall 64% this year to $13.5 billion from $37.8 billion in 2022. Paxlovid’s revenue is expected to fall 58% from $18.9 billion in 2022 to $8 billion in 2023.

Pfizer also forecasts full-year earnings per share to fall by as much as 50% to between $3.25 and $3.45 from a record EPS of $6.58 in 2022.

The company’s fourth-quarter results were broadly in line with analysts’ expectations.

Pfizer CEO Albert Bourla last quarter laid out a growth plan for the company through 2030 that looks beyond the pandemic. Bourla said he sees future sales growth from RSV vaccines and drugs for migraine and ulcerative colitis, among other drugs.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Weight problems related to Azheimer-like modifications within the mind

Obesity can cause changes in the brain similar to the symptoms of Alzheimer’s disease, according to a new study.

The disturbing link was uncovered in a study of more than 1,300 people

Scientists from the Montreal Neurological Institute (affiliated with McGill University) conducted the research, and the results have just been published in the Journal of Alzheimer’s Disease.

Analyzing brain scans of over 1,300 people, the researchers found similar patterns of “brain atrophy” in patients with Alzheimer’s and others classified as “obese.” Specifically, they found that both groups exhibited “widespread reduced cortical thickness” in areas of the brain that impact learning, memory and judgment.

Remarkably, these similarities were not observed in other patients classified as “lean”.

Researchers believe that “management of obesity” may help reduce the risk of “grey matter atrophy associated with obesity.”

As a result of the study, the researchers eventually discovered that “grey matter atrophy associated with obesity resembles that of atrophy [Alzheimer’s disease].”

In addition, they also found that “obesity management” could potentially lower the risk of the condition. This finding appears to build on previous research suggesting that obese people may develop Alzheimer’s at a younger age.

“Our research confirms that obesity-induced gray matter atrophy resembles that of AD. Obesity management could lead to improved health outcomes, slow cognitive decline with age, and reduce risk of Alzheimer’s.”

So while much is still unknown about Alzheimer’s disease, it appears that a healthier lifestyle and controlled weight can help reduce the risk of developing similar symptoms.

Indeed, the researchers state, “Our results underscore the importance of interventions aimed at reducing weight and metabolic risk factors in obese and overweight individuals in midlife to reduce the subsequent risk of neurodegeneration and dementia in the population.”

As Linda Van Horn – nutrition chief at Northwestern University’s Feinberg School of Medicine – tells NBC News, losing weight may not be able to reverse damage already done. Finally, “there are certain points of no return.”

“Unfortunately, we are discovering more and more that there are certain points of no return. I believe, based on examples such as osteoporosis, that the chances of reversing the disease are lower than those of maintaining the current one.”

What do you think of these findings?

Alec Baldwin has been formally charged with filming the Rust film

Santa Fe prosecutors on Tuesday filed two counts of involuntary manslaughter charges against Alec Baldwin for fatally shooting on the set of the movie Rust.

They claimed the actor was not properly trained to handle the gun that ultimately killed cinematographer Halyna Hutchins.

Hannah Gutierrez-Reed, the film’s gunsmith, was also charged with the same two counts of involuntary manslaughter. David Halls, the assistant director of “Rust” who also had a hand in handling the gun that killed Hutchins, signed a plea deal that suspended his sentence and granted him six months probation.

“Today we took another important step to bring justice to Halyna Hutchins,” said Mary Carmack-Altwies, New Mexico First Judicial District Attorney. “In New Mexico, no one is above the law and justice is done.”

Baldwin’s attorneys did not immediately comment.

Baldwin was “distracted and constantly talking to his family on his cellphone” during a more than hour-long firearms training session, according to a statement of likely cause filed in conjunction with the charges. Because of Baldwin’s distractions, the prosecutor said the training he received was estimated at 30 minutes.

In addition to starring in the film, Baldwin was one of the producers, blaming him for following safety protocols and hiring Gutierrez-Reed despite her lack of qualifications.

“Baldwin, by act or omission or omission to act in his position as producer, during a very short period of time, directly contributed and/or failed to mitigate reckless and dangerous acts,” alleges the Attorney’s Office, which alleges that at least a dozen “negligent acts or omissions” occurred on the day of shooting alone.

According to the probable cause statement, Baldwin “has publicly claimed that he is an ‘…expert…’ in the field of firearms and filmmaking”.

“Reed knew Baldwin needed more training,” which “could have prevented the fatal shooting,” the prosecutor said, citing a statement Gutierrez-Reed made in her testimony.

According to a report by the Los Angeles Times, a half-dozen members of the film crew left the set hours before filming began to protest what they saw as harsh and unsafe working conditions.

Gutierrez-Reed’s attorneys pushed back the probable cause statement, saying the prosecutor “completely misunderstood the facts” and “reached the wrong conclusions.” They also said she was “rejected and brushed aside” when she asked to offer more firearms training.

“She was told by the production to focus on props. Hannah asked Halls if they could send us a plastic gun for the rehearsal scene and he said no because he wanted a ‘real gun’. Hannah asked to be called back to the church if Baldwin even used the gun, and Halls didn’t,” attorneys Jason Bowles and Todd Bullion said in a statement.

“Nevertheless, the District Attorney has issued Halls with a 6-month suspended sentence and charged Hannah and Baldwin with felonies that carry a minimum of 5 years in prison. The tragedy is that if Hannah had just been called back to the church by Halls, she would have played the inspection and prevented this tragedy,” they added.

Authorities announced earlier this month that they would be filing criminal charges in the case.

Documents filed in connection with the charges say that in October 2021, Baldwin had not been properly trained to use the gun that killed Hutchins and injured Joel Souza, the film’s director.

Evidence from the Santa Fe prosecutor’s office also alleges that Gutierrez-Reed was not qualified to play the gunsmith for the film because she had not held “certification or certifiable training or a union card” for the practice, and that she admitted that She was Armorer for only one film prior to this production.”

Baldwin and Gutierrez-Reed both face two counts of involuntary manslaughter. Both are felonies punishable by a $5,000 fine, but one carries an 18-month prison sentence while the other carries a five-year sentence.

The two were charged under a standard called alternative charges, meaning a jury will decide which of the two counts of manslaughter applies.

George Santos’ finish is close to as he resigns from committees

Rep. George Santos (R-NY)’s resignation from committees is a sign his legal troubles are mounting and his time in Congress may soon be ending.

The AP reports:

Republican Rep. George Santos of New York told GOP colleagues Tuesday that he was temporarily stepping down from both of his congressional committees, a move amid a host of ethics issues and a day after he met House Speaker Kevin McCarthy .

Santos has faced numerous resignation calls and faces multiple investigations from prosecutors over his personal and campaign finances and lies about his resume and family background.

Rep. Santos is not stepping down from his committee duties over an investigation into House ethics or campaign finance violations.

There are ongoing criminal investigations into where George Santos got his money and how hundreds of thousands of dollars from mysterious sources ended up in his congressional campaign.

Subscribe to our newsletter:

House Republicans are over the moon because they want to keep Rep. Santos’ vote but also make him disappear.

It doesn’t matter if Santos serves on committees or not. The story won’t go away as long as he stays in the house.

House Republicans and George Santos are linked at the hip. Santos will be the face of the Democratic campaign to take back the house in 2024.

George Santos can’t hide from the law, and House Republicans can’t hide Rep. Santos in Congress.

Jason is the managing editor. He is also a White House press pool and congressional correspondent for PoliticusUSA. Jason has a bachelor’s degree in political science. His thesis focused on public policy with a specialization in social reform movements.

Awards and professional memberships

Member of the Society of Professional Journalists and the American Political Science Association

Pfizer (PFE) This autumn Outcomes 2022

Vials of the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic in Valparaiso, Chile, on January 3, 2022.

Rodrigo Garrido | Reuters

Pfizer issued a sales guidance of $67 billion to $71 billion for 2023 on Tuesday, down from record 2022 results.

The drug company booked $100.3 billion for full-year 2022, an all-time high, driven by more than $50 billion in sales of Covid vaccines and antivirals.

Pfizer expects sales for 2023 to fall by as much as 33% compared to 2022 as the pandemic eases and demand for its Covid portfolio falls. The company expects $13.5 billion in 2023 Covid vaccine sales and $8 billion in revenue for Paxlovid.

Pfizer is forecasting earnings of between $3.25 and $3.45 per share for 2023, down 50% from a record $6.58 in 2022. The company reported net income of $31.4 billion in 2022, a 43% increase from 2021.

Pfizer’s stock fell 3% in premarket trading.

The drugmaker’s fourth-quarter results broadly met analysts’ expectations. The company reported net income of nearly $5 billion for the quarter, up 47% from the same period in 2021. It generated revenue of $24.3 billion for the quarter.

Here’s how the company performed versus Wall Street’s expectations for the fourth quarter, based on average analyst estimates compiled by Refinitiv:

  • Adjusted earnings per share: $1.14 versus $1.05 expected
  • Revenues: $24.3 billion versus $24.28 billion

CNBC Health & Science

Read CNBC’s latest global health coverage: